Method of treating cancer with a combination of an anti-CCR4 antibody and a 4-1BB agonist

摘要

The present disclosure describes combination therapies comprising an antibody which specifically binds to human CCR4 and a selective 4-1BB agonist, and the use of the combination therapies for the treatment of cancer.